Skip to content
  • Login
  • Signup
  • Cart ( )
  • Login
  • Signup
  • Cart ( )
  • About
  • Reports Type
      • Product Specific Reports
      • Techno Commercial
        • Detailed Project Report (DPR)
        • Detailed Feasibility Report (DFR)
      • Market Survey
        • New Launch Survey
        • Post Launch Survey
      • Competitive Intelligence
        • Global Competitive Intelligence
        • Global End User Intelligence
      • Company Specific Reports
      • Due-Diligence
        • Company Profiling
        • Pipeline Analysis
        • Technological Due-Diligence
        • Financial Due-Diligence
      • Premium Reports
      • Landscape Studies
        • Technology Level
        • Therapeutic Areas Level
        • Indication/Disease Level
        • API (Chemical)
        • API (Biological)
      • Patent Analytics
        • Prior Art Search
        • Freedom To Operate (FTO)
        • Patent Invalidation
        • Patent Landscape
        • Patent Watch
  • Industry
  • Research Methodology
  • Market Pulse
  • Blogs
  • Subscription
  • Contact Us
marketsandsurveys

Analysis : How top 10 Pharma Companies fared in 2020 & 2021?

admin
20 April 2022
No Comments

The Pharmaceutical market has undergone a radical phase of growth during the year 2020-2021. Pfizer’s record-breaking year set the tone

read more
marketsandsurveys

Anti-Allergy Market

admin
22 February 2022
No Comments

Introduction: At a Global level, allergies affect over 500 million people, where surprisingly over 100 million people are from India.

read more
marketsandsurveys

Lifescience Intellipedia-M&S released Molnupiravir global market report 2022;

admin
4 January 2022
No Comments

Lifescience Intellipedia-M&S released Molnupiravir global market report 2022; the Optimus Pharma, Cipla, Strides, Mylan, Emcure, Dr Reddy’s, Sun Pharma and

read more
marketsandsurveys

Share listed of Supriya Lifescience

admin
28 December 2021
No Comments

Supriya Lifescience Share Listed today on BSE, NSE Opens at 55% Premium at BSE and 53% Premium at NSE; Lifescience

read more
marketsandsurveys

Supriya Lifescience IPO

admin
22 December 2021
No Comments

Lifescience Intellipedia is one of the data sourcing partners for Supriya Lifesciences DRHP; Supriya Lifesciences to raise INR 1200 crore

read more

Recent Posts

  • Analysis : How top 10 Pharma Companies fared in 2020 & 2021?
  • Anti-Allergy Market
  • Lifescience Intellipedia-M&S released Molnupiravir global market report 2022;
  • Share listed of Supriya Lifescience
  • Supriya Lifescience IPO
  • C-89, 1st floor, Sector-65, Noida-201301, India
  • +91-120-6631301-335
  • sales@lifescienceintellipedia.com
    info@lifescienceintellipedia.com

Services

  • Due-Diligence
    • Company Profiling
    • Pipeline Analysis
    • Technological Due-Diligence
    • Financial Due-Diligence
  • Landscape Studies
    • Emerging Industry
    • Therapeutic Areas
    • Induction
    • API (Chemical)
    • API (Biological)
  • Patent Analytics
    • Prior Art Search
    • Freedom To Operate (FTO)
    • Patent Invalidation
    • Patent Landscape
    • Patent Watch
  • Techno Commercial
    • Detailed Project Report
    • Techno Commercial Feasibility ( DPR With Investment & Feasibility ) Report
  • Market Survey
    • New Launch Survey
    • Post Launch Survey
  • Buyer-Supplier
    • Global Producers
    • Global Buyers
    • Indian Producers
    • Indian Buyers

Quick Links

  • About
  • Our Team
  • Industry
  • R&M
  • Order History
  • Market Pulse
  • Available Pulse
  • Contact Us
  • Privacy Policy
  • Refund Policy
  • T&C

Follow Us

2020 © All Rights Reserved by Lifescience Intellipedia Pvt. Ltd. Number of visitors : 1956635